Logo image of NCA

NUVEEN CALIFORNIA MUNI VAL (NCA) Stock Price, Quote, News and Overview

NYSE:NCA - New York Stock Exchange, Inc. - US67062C1071 - Currency: USD

8.45  0 (0%)

Fundamental Rating

3

Overall NCA gets a fundamental rating of 3 out of 10. We evaluated NCA against 0 industry peers in the Unkown industry. While NCA seems to be doing ok healthwise, there are quite some concerns on its profitability. NCA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year NCA was profitable.
In the past year NCA had a positive cash flow from operations.
In multiple years NCA reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: NCA reported negative operating cash flow in multiple years.
NCA Yearly Net Income VS EBIT VS OCF VS FCFNCA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

Industry RankSector Rank
ROA 3.19%
ROE 3.2%
ROIC 2.97%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCA Yearly ROA, ROE, ROICNCA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

NCA's Profit Margin has improved in the last couple of years.
NCA's Operating Margin has improved in the last couple of years.
In the last couple of years the Gross Margin of NCA has remained more or less at the same level.
Industry RankSector Rank
OM 87.16%
PM (TTM) 74.16%
GM 99.77%
OM growth 3Y2.6%
OM growth 5Y1.81%
PM growth 3YN/A
PM growth 5Y14.25%
GM growth 3Y0.1%
GM growth 5Y0.05%
NCA Yearly Profit, Operating, Gross MarginsNCA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200 300

6

2. Health

2.1 Basic Checks

NCA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NCA Yearly Shares OutstandingNCA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
NCA Yearly Total Debt VS Total AssetsNCA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

NCA has an Altman-Z score of 140.03. This indicates that NCA is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for NCA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 140.03
ROIC/WACCN/A
WACCN/A
NCA Yearly LT Debt VS Equity VS FCFNCA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 4.08 indicates that NCA has no problem at all paying its short term obligations.
NCA has a Quick Ratio of 4.08. This indicates that NCA is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 4.08
Quick Ratio 4.08
NCA Yearly Current Assets VS Current LiabilitesNCA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

1

3. Growth

3.1 Past

The earnings per share for NCA have decreased strongly by -43.40% in the last year.
Measured over the past years, NCA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.82% on average per year.
The Revenue has decreased by -0.15% in the past year.
Measured over the past years, NCA shows a small growth in Revenue. The Revenue has been growing by 2.66% on average per year.
EPS 1Y (TTM)-43.4%
EPS 3YN/A
EPS 5Y12.82%
EPS Q2Q%-75%
Revenue 1Y (TTM)-0.15%
Revenue growth 3Y6.84%
Revenue growth 5Y2.66%
Sales Q2Q%0%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCA Yearly Revenue VS EstimatesNCA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 28.17, NCA can be considered very expensive at the moment.
NCA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.17
Fwd PE N/A
NCA Price Earnings VS Forward Price EarningsNCA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 15.54
EV/EBITDA N/A
NCA Per share dataNCA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.2
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.13%, NCA is a good candidate for dividend investing.
NCA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 4.13%

5.2 History

NCA has paid a dividend for at least 10 years, which is a reliable track record.
NCA has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
NCA Yearly Dividends per shareNCA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

NCA pays out 122.95% of its income as dividend. This is not a sustainable payout ratio.
DP122.95%
EPS Next 2YN/A
EPS Next 3YN/A
NCA Yearly Income VS Free CF VS DividendNCA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M
NCA Dividend Payout.NCA Dividend Payout, showing the Payout Ratio.NCA Dividend Payout.PayoutRetained Earnings

NUVEEN CALIFORNIA MUNI VAL

NYSE:NCA (6/18/2025, 8:11:59 PM)

8.45

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-03 2025-05-03
Earnings (Next)11-08 2025-11-08
Inst Owners22.4%
Inst Owner Change32.47%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap279.78M
Analysts81.43
Price TargetN/A
Short Float %0.18%
Short Ratio0.68
Dividend
Industry RankSector Rank
Dividend Yield 4.13%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP122.95%
Div Incr Years0
Div Non Decr Years3
Ex-Date06-13 2025-06-13 (0.029)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 28.17
Fwd PE N/A
P/S 21.26
P/FCF 15.54
P/OCF 15.54
P/B 0.92
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)0.3
EY3.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.54
FCFY6.43%
OCF(TTM)0.54
OCFY6.43%
SpS0.4
BVpS9.21
TBVpS9.21
PEG (NY)N/A
PEG (5Y)2.2
Profitability
Industry RankSector Rank
ROA 3.19%
ROE 3.2%
ROCE 3.76%
ROIC 2.97%
ROICexc 2.99%
ROICexgc 2.99%
OM 87.16%
PM (TTM) 74.16%
GM 99.77%
FCFM 136.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y2.6%
OM growth 5Y1.81%
PM growth 3YN/A
PM growth 5Y14.25%
GM growth 3Y0.1%
GM growth 5Y0.05%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 184.43%
Current Ratio 4.08
Quick Ratio 4.08
Altman-Z 140.03
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.4%
EPS 3YN/A
EPS 5Y12.82%
EPS Q2Q%-75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.15%
Revenue growth 3Y6.84%
Revenue growth 5Y2.66%
Sales Q2Q%0%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.69%
EBIT growth 3Y9.62%
EBIT growth 5Y4.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y168.89%
FCF growth 3YN/A
FCF growth 5Y17.29%
OCF growth 1Y168.89%
OCF growth 3YN/A
OCF growth 5Y17.29%